NLRP3 and metabolic dysfunction-associated steatotic liver disease: Lebeaupin and colleagues [31] demonstrated that the ER stress signaling pathway increased NLRP3 inflammasome activation and hepatocyte death and consequently led to nonalcoholic fatty liver disease.